Advertisement

Quality of Life Research

, Volume 17, Issue 4, pp 559–574 | Cite as

Quality of life in age-related macular degeneration: a review of available vision-specific psychometric tools

  • Robert P. Finger
  • Monika Fleckenstein
  • Frank G. Holz
  • Hendrik P. N. Scholl
Article

Abstract

Purpose

Age-related macular degeneration (AMD) has a considerable impact on older adults’ independence and autonomy. Recently, patient reported outcomes (PROs) such as QoL have been met with increasing interest by the scientific community, healthcare payers and planners. Against this background, the multitude of psychometric tools used to measure QoL in AMD was reviewed.

Methods

A search of the literature from 1990 onwards yielded 355 results, out of which 58 publications were included in the review. Data regarding design, validation and extent of utilization were obtained where available.

Results

The National Eye Institute–Visual Function Questionnaire (NEI VFQ-25-item) was found to be the most often used (29% of studies) and best validated psychometric tool, followed by the Visual Function Questionnaire (VF-14; 17%), and the Impact of Vision Impairment Profile (IVI; 9%). Most tools that were identified have been validated for the use in AMD patients.

Conclusion

Psychometric tools specifically designed to measure vision-related quality of life are well equipped and validated to measure QoL in AMD. More recent developments such as the Macular Disease-dependent Quality of Life (MacDQoL) questionnaire might be able to depict dimensions of vision-related QoL in greater depth. Future studies should endeavour to use a suggested standard when gathering data on vision related QoL, allowing for international comparisons.

Keywords

Age-related macular degeneration (AMD) Quality of life Psychometric tools Psychometric and non-psychometric properties Quality criteria 

Abbreviations

ADVS

Activities of daily life dependent upon vision

AMD

Age-related macular degeneration

DLTV

Daily living tasks dependend upon vision

EMEA

European Agency for the Evaluation of Medicinal Products

FDA

Food and Drug Administration

HrQoL

Health-related Quality of life

IVI

Impact of vision impairment

MacDQoL

Macular Disease-dependent Quality of Life (MacDQoL) questionnaire

NEI VFQ

National Eye Institute Vision Function Questionnaire

PDT

Photodynamic therapy

PRO

Patient reported outcomes

QoL

Quality of life

SST

Submacular Surgery Trial

TRR

Test-retest reliability

VF-14

Vision function questionnaire 14 items

VCM1

Vision-related quality of life questionnaire, core instrument

VEGF

vascular endothelial growth factor

Notes

Acknowledgements

The research was supported by The Deutsche Forschungsgemeinschaft: Heisenberg fellowship SCHO 734/2-1; and EU FP6, Integrated Project “EVI-GENORET” (LSHG-CT-2005-512036).

References

  1. 1.
    Fine S. L., Berger J. W., Maguire M. G., & Ho A. C. (2000). Age-related macular degeneration. The New England Journal of Medicine 342, 483–492.PubMedCrossRefGoogle Scholar
  2. 2.
    Trautner C., Haastert B., Richter B., Berger M., & Giani G. (2003). Incidence of blindness in southern Germany due to glaucoma and degenerative conditions. Investigative Ophthalmology & Visual Science, 44, 1031–1034.CrossRefGoogle Scholar
  3. 3.
    Birk T., Hickl S., Wahl H. W., Miller D., Kammerer A., Holz F., Becker S., & Volcker H. E. (2004). Development and pilot evaluation of a psychosocial intervention program for patients with age-related macular degeneration. Gerontologist, 44, 836–843.PubMedGoogle Scholar
  4. 4.
    de Jong P. T. (2006). Age-related macular degeneration. The New England Journal of Medicine, 355, 1474–1485.PubMedCrossRefGoogle Scholar
  5. 5.
    Holz F. G., Pauleikhoff D., Klein R., & Bird A. C. (2004). Pathogenesis of lesions in late age-related macular disease. American Journal of Ophthalmology, 137, 504–510.PubMedCrossRefGoogle Scholar
  6. 6.
    Eter N., Krohne T. U., & Holz F. G. (2006). New pharmacologic approaches to therapy for age-related macular degeneration. BioDrugs, 20, 167–179.PubMedCrossRefGoogle Scholar
  7. 7.
    The Age-related Eye Disease Study Research Group. (2001). A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8. Archives of Ophthalmology, 119, 1417–1436.Google Scholar
  8. 8.
    Slakter J. S., & Stur M. (2005). Quality of life in patients with age-related macular degeneration: Impact of the condition and benefits of treatment. Survey of Ophthalmology, 50, 263–273.PubMedCrossRefGoogle Scholar
  9. 9.
    Brody B. L., Gamst A. C., Williams R. A., Smith A. R., Lau P. W., Dolnak D., Rapaport M. H., Kaplan R. M., & Brown S. I. (2001). Depression, visual acuity, comorbidity, and disability associated with age-related macular degeneration. Ophthalmology, 108, 1893–1900, discussion 1900–1891.PubMedCrossRefGoogle Scholar
  10. 10.
    Brody B. L., Williams R. A., Thomas R. G., Kaplan R. M., Chu R. M., & Brown S. I. (1999). Age-related macular degeneration: A randomized clinical trial of a self-management intervention. Annals of Behavioural Medicine, 21, 322–329.CrossRefGoogle Scholar
  11. 11.
    Williams R. A., Brody B. L., Thomas R. G., Kaplan R. M., & Brown S. I. (1998). The psychosocial impact of macular degeneration. Archives of Ophthalmology, 116, 514–520.PubMedGoogle Scholar
  12. 12.
    O’Shaughnessy J. A., Wittes R. E., Burke G., Friedman M. A., Johnson J. R., Niederhuber J. E., Rothenberg M. L., Woodcock J., Chabner B. A., & Temple R. (1991). Commentary concerning demonstration of safety and efficacy of investigational anticancer agents in clinical trials. Journal of Clinical Oncology, 9, 2225–2232.PubMedGoogle Scholar
  13. 13.
    Committee for Medicinal Products for Human Use (CHMP). (2005). Reflection Paper on the regulatory guidance for the use of healthrelated quality of life (HRQL) measures in the evaluation of medicinal products. In: EMEA, London.Google Scholar
  14. 14.
    Chassany O., Sagnier P., Marquis P., Fullerton S., & Aaronson N. (2002). Patient—reported outcomes: The example of health-related quality of life—A European guidance document for the improved integration of health-related quality of life assessment in the drug regulatory process. Drug Information Journal, 36, 209–238.Google Scholar
  15. 15.
    Cahill M. T., Banks A. D., Stinnett S. S., & Toth C. A. (2005). Vision-related quality of life in patients with bilateral severe age-related macular degeneration. Ophthalmology, 112, 152–158.PubMedCrossRefGoogle Scholar
  16. 16.
    Margolis M. K., Coyne K., Kennedy-Martin T., Baker T., Schein O., & Revicki D. A. (2002). Vision-specific instruments for the assessment of health-related quality of life and visual functioning: A literature review. Pharmacoeconomics, 20, 791–812.PubMedCrossRefGoogle Scholar
  17. 17.
    de Boer M. R., Moll A. C., de Vet H. C., Terwee C. B., Volker-Dieben H. J., & van Rens G. H. (2004). Psychometric properties of vision-related quality of life questionnaires: A systematic review. Ophthalmic & Physiological Optics, 24, 257–273.CrossRefGoogle Scholar
  18. 18.
    Mangione C. M., Phillips R. S., Seddon J. M., Lawrence M. G., Cook E. F., Dailey R., & Goldman L. (1992). Development of the ‘Activities of Daily Vision Scale’. A measure of visual functional status. Medical Care, 30, 1111–1126.PubMedCrossRefGoogle Scholar
  19. 19.
    Pesudovs K., & Coster D. J. (1998). An instrument for assessment of subjective visual disability in cataract patients. The British Journal of Ophthalmology, 82, 617–624.PubMedGoogle Scholar
  20. 20.
    Pesudovs K., Garamendi E., Keeves J. P., & Elliott D. B. (2003). The activities of daily vision scale for cataract surgery outcomes: Re-evaluating validity with Rasch analysis. Investigative Ophthalmology & Visual Science 44, 2892–2899.CrossRefGoogle Scholar
  21. 21.
    Hart P. M., Chakravarthy U., Stevenson M. R., & Jamison J. Q. (1999). A vision specific functional index for use in patients with age related macular degeneration. The British Journal of Ophthalmology, 83, 1115–1120.PubMedGoogle Scholar
  22. 22.
    Hart P. M., Stevenson M. R., Montgomery A. M., Muldrew K. A., & Chakravarthy U. (2005). Further validation of the daily living tasks dependent on vision: Identification of domains. The British Journal of Ophthalmology, 89, 1127–1130.PubMedCrossRefGoogle Scholar
  23. 23.
    Schmier J. K., Halpern M. T., & Covert D. (2006). Validation of the daily living tasks dependent on vision (DLTV) questionnaire in a U.S. population with age-related macular degeneration. Ophthalmic Epidemiology, 13, 137–143.PubMedCrossRefGoogle Scholar
  24. 24.
    McClure M. E., Hart P. M., Jackson A. J., Stevenson M. R., & Chakravarthy U. (2000). Macular degeneration: Do conventional measurements of impaired visual function equate with visual disability? The British Journal of Ophthalmology, 84, 244–250.PubMedCrossRefGoogle Scholar
  25. 25.
    Lamoureux E. L., Pallant J. F., Pesudovs K., Rees G., Hassell J. B., & Keeffe J. E. (2007). The impact of vision impairment questionnaire: An assessment of its domain structure using confirmatory factor analysis and rasch analysis. Investigative Ophthalmology & Visual Science, 48, 1001–1006.CrossRefGoogle Scholar
  26. 26.
    Lamoureux E. L., Pallant J. F., Pesudovs K., Hassell J. B., & Keeffe J. E. (2006). The impact of vision impairment questionnaire: An evaluation of its measurement properties using Rasch analysis. Investigative Ophthalmology & Visual Science, 47, 4732–4741.CrossRefGoogle Scholar
  27. 27.
    Hassell J. B., Weih L. M., & Keeffe J. E. (2000). A measure of handicap for low vision rehabilitation: The impact of vision impairment profile. Clinical & Experiment Ophthalmology, 28, 156–161.CrossRefGoogle Scholar
  28. 28.
    Mitchell J., & Bradley C. (2004). Design of an individualised measure of the impact of macular disease on quality of life (the MacDQoL). Quality of Life Research, 13, 1163–1175.PubMedCrossRefGoogle Scholar
  29. 29.
    Mitchell J., Wolffsohn J. S., Woodcock A., Anderson S. J., McMillan C. V., Ffytche T., Rubinstein M., Amoaku W., & Bradley C. (2005). +Psychometric evaluation of the MacDQoL individualised measure of the impact of macular degeneration on quality of life. Health and Quality of Life Outcomes, 3, 25.PubMedCrossRefGoogle Scholar
  30. 30.
    Mangione C. M., Lee P. P., Gutierrez P. R., Spritzer K., Berry S., & Hays R. D. (2001). Development of the 25-item National Eye Institute Visual Function Questionnaire. Archives of Ophthalmology, 119, 1050–1058.PubMedGoogle Scholar
  31. 31.
    Miskala P. H., Hawkins B. S., Mangione C. M., Bass E. B., Bressler N. M., Dong L. M., Marsh M. J., & McCaffrey L. D. (2003). Responsiveness of the National Eye Institute Visual Function Questionnaire to changes in visual acuity: Findings in patients with subfoveal choroidal neovascularization–SST Report No. 1. Archives of Ophthalmology, 121, 531–539.PubMedCrossRefGoogle Scholar
  32. 32.
    Mangione C. M., Lee P. P., Pitts J., Gutierrez P., Berry S., & Hays R. D. (1998). Psychometric properties of the National Eye Institute Visual Function Questionnaire (NEI-VFQ). NEI-VFQ field test investigators. Archives of Ophthalmology, 116, 1496–1504.PubMedGoogle Scholar
  33. 33.
    Mangione C. M., Berry S., Spritzer K., Janz N. K., Klein R., Owsley C., & Lee P. P. (1998). Identifying the content area for the 51-item national eye institute visual function questionnaire: Results from focus groups with visually impaired persons. Archives of Ophthalmology, 116, 227–233.PubMedGoogle Scholar
  34. 34.
    Steinberg E. P., Tielsch J. M., Schein O. D., Javitt J. C., Sharkey P., Cassard S. D., Legro M. W., Diener-West M., Bass E. B., & Damiano A. M., et al. (1994). The VF-14. An index of functional impairment in patients with cataract. Archives of Ophthalmology, 112, 630–638.PubMedGoogle Scholar
  35. 35.
    Linder M., Chang T. S., Scott I. U., Hay D., Chambers K., Sibley L. M., & Weis E. (1999). Validity of the visual function index (VF-14) in patients with retinal disease. Archives of Ophthalmology, 117, 1611–1616.PubMedGoogle Scholar
  36. 36.
    Riusala A., Sarna S., & Immonen I. (2003). Visual function index (VF-14) in exudative age-related macular degeneration of long duration. American Journal of Ophthalmology, 135, 206–212.PubMedCrossRefGoogle Scholar
  37. 37.
    Cassard S. D., Patrick D. L., Damiano A. M., Legro M. W., Tielsch J. M., Diener-West M., Schein O. D., Javitt J. C., Bass E. B., & Steinberg E. P. (1995). Reproducibility and responsiveness of the VF-14. An index of functional impairment in patients with cataracts. Archives of Ophthalmology, 113, 1508–1513.PubMedGoogle Scholar
  38. 38.
    Lindblad A. S., & Clemons T. E. (2005). Responsiveness of the National Eye Institute Visual Function Questionnaire to progression to advanced age-related macular degeneration, vision loss, and lens opacity: AREDS Report no. 14. Archives of Ophthalmology, 123, 1207–1214.PubMedCrossRefGoogle Scholar
  39. 39.
    Clemons T. E., Chew E. Y., Bressler S. B., & McBee W. (2003). National Eye Institute Visual Function Questionnaire in the Age-Related Eye Disease Study (AREDS): AREDS Report No. 10. Archives of Ophthalmology, 121, 211–217.PubMedGoogle Scholar
  40. 40.
    Suzukamo Y., Oshika T., Yuzawa M., Tokuda Y., Tomidokoro A., Oki K., Mangione C. M., Green J., & Fukuhara S. (2005). Psychometric properties of the 25-item National Eye Institute Visual Function Questionnaire (NEI VFQ-25), Japanese version. Health and Quality of Life Outcomes, 3, 65.PubMedCrossRefGoogle Scholar
  41. 41.
    Toprak A. B., Eser E., Guler C., Baser F. E., & Mayali H. (2005). Cross-validation of the Turkish version of the 25-item National Eye Institute Visual Functioning Questionnaire (NEI-VFQ 25). Ophthalmic Epidemiology, 12, 259–269.PubMedCrossRefGoogle Scholar
  42. 42.
    Rossi G. C., Milano G., & Tinelli C. (2003). The Italian version of the 25-item National Eye Institute Visual Function Questionnaire: Translation, validity, and reliability. Journal of Glaucoma, 12, 213–220.PubMedCrossRefGoogle Scholar
  43. 43.
    Hudson H. L., Lane S. S., Heier J. S., Stulting R. D., Singerman L., Lichter P. R., Sternberg P., & Chang D. F. (2006). Implantable miniature telescope for the treatment of visual acuity loss resulting from end-stage age-related macular degeneration: 1-Year results. Ophthalmology, 113, 1987–2001.PubMedCrossRefGoogle Scholar
  44. 44.
    Fuhs A., Dasch B., Behrens T., Meister A., Krause K., Pauleikhoff D., & Hense H. W. (2005). Visual function and quality of life in patients with age-related maculopathy: Results of the Munster Age and Retina Study (MARS). Klin Monatsbl Augenheilkd, 222, 649–654.PubMedCrossRefGoogle Scholar
  45. 45.
    Cahill M. T., Stinnett S. S., Banks A. D., Freedman S. F., & Toth C. A. (2005). Quality of life after macular translocation with 360 degrees peripheral retinectomy for age-related macular degeneration. Ophthalmology, 112, 144–151.PubMedCrossRefGoogle Scholar
  46. 46.
    Miskala P. H., Bass E. B., Bressler N. M., Childs A. L., Hawkins B. S., Mangione C. M., & Marsh M. J. (2004). Surgery for subfoveal choroidal neovascularization in age-related macular degeneration: Quality-of-life findings: SST report no. 12. Ophthalmology, 111, 1981–1992.PubMedCrossRefGoogle Scholar
  47. 47.
    Childs A. L., Bressler N. M., Bass E. B., Hawkins B. S., Mangione C. M., Marsh M. J., & Miskala P. H. (2004). Surgery for hemorrhagic choroidal neovascular lesions of age-related macular degeneration: Quality-of-life findings: SST report no. 14. Ophthalmology, 111, 2007–2014.PubMedCrossRefGoogle Scholar
  48. 48.
    Scilley K., DeCarlo D. K., Wells J., & Owsley C. (2004). Vision-specific health-related quality of life in age-related maculopathy patients presenting for low vision services. Ophthalmic Epidemiology, 11, 131–146.PubMedCrossRefGoogle Scholar
  49. 49.
    Dong L. M., Childs A. L., Mangione C. M., Bass E. B., Bressler N. M., Hawkins B. S., Marsh M. J., Miskala P., Jaffee H. A., & McCaffrey L. A. (2004). Health- and vision-related quality of life among patients with choroidal neovascularization secondary to age-related macular degeneration at enrollment in randomized trials of submacular surgery: SST report no. 4. American Journal of Ophthalmology, 138, 91–108.PubMedCrossRefGoogle Scholar
  50. 50.
    Maguire M. (2004). Baseline characteristics, the 25-item National Eye Institute Visual Functioning Questionnaire, and their associations in the Complications of Age-Related Macular Degeneration Prevention Trial (CAPT). Ophthalmology, 111, 1307–1316.PubMedCrossRefGoogle Scholar
  51. 51.
    Varma R., Paz S. H., Azen S. P., Klein R., Globe D., Torres M., Shufelt C., & Preston-Martin S. (2004). The Los Angeles Latino Eye Study: Design, methods, and baseline data. Ophthalmology, 111, 1121–1131.PubMedCrossRefGoogle Scholar
  52. 52.
    DeCarlo D. K., Scilley K., Wells J., & Owsley C. (2003). Driving habits and health-related quality of life in patients with age-related maculopathy. Optom Vis Sci, 80, 207–213.PubMedCrossRefGoogle Scholar
  53. 53.
    Berdeaux G. H., Nordmann J. P., Colin E., & Arnould B. (2005). Vision-related quality of life in patients suffering from age-related macular degeneration. American Journal of Ophthalmology, 139, 271–279.PubMedCrossRefGoogle Scholar
  54. 54.
    Brody B. L., Roch-Levecq A. C., Thomas R. G., Kaplan R. M., & Brown S. I. (2005). Self-management of age-related macular degeneration at the 6-month follow-up: A randomized controlled trial. Archives of Ophthalmology, 123, 46–53.PubMedCrossRefGoogle Scholar
  55. 55.
    Brody B. L., Roch-Levecq A. C., Gamst A. C., Maclean K., Kaplan R. M., & Brown S. I. (2002). Self-management of age-related macular degeneration and quality of life: A randomized controlled trial. Archives of Ophthalmology, 120, 1477–1483.PubMedGoogle Scholar
  56. 56.
    Miskala P. H., Bressler N. M., & Meinert C. L. (2004). Relative contributions of reduced vision and general health to NEI-VFQ scores in patients with neovascular age-related macular degeneration. Archives of Ophthalmology, 122, 758–766.PubMedCrossRefGoogle Scholar
  57. 57.
    Bansback N., Czoski-Murray C., Carlton J., Lewis G., Hughes L., Espallargues M., Brand C., & Brazier J. (2007). Determinants of health related quality of life and health state utility in patients with age related macular degeneration: The association of contrast sensitivity and visual acuity. Quality of Life Research, 16, 533–543.PubMedCrossRefGoogle Scholar
  58. 58.
    Pham T. Q., Cugati S., Rochtchina E., Mitchell P., Maloof A., & Wang J. J. (2007). Age-related maculopathy and cataract surgery outcomes: Visual acuity and health-related quality of life. Eye, 21, 324–330.PubMedCrossRefGoogle Scholar
  59. 59.
    Hewitt A. W., Jeganathan V. S., Kidd J. E., Pesudovs K., & Verma N. (2006). Influence of photodynamic therapy for age related macular degeneration upon subjective vision related quality of life. Graefes Archive for Clinical and Experimental Ophthalmology, 244, 972–977.CrossRefGoogle Scholar
  60. 60.
    Armbrecht A. M., Aspinall P. A., & Dhillon B. (2004). A prospective study of visual function and quality of life following PDT in patients with wet age related macular degeneration. The British Journal of Ophthalmology 88, 1270–1273.PubMedCrossRefGoogle Scholar
  61. 61.
    Armbrecht A. M., Findlay C., Aspinall P. A., Hill A. R., & Dhillon B. (2003). Cataract surgery in patients with age-related macular degeneration: One-year outcomes. Journal of Cataract and Refractive Surgery, 29, 686–693.PubMedCrossRefGoogle Scholar
  62. 62.
    Mackenzie P. J., Chang T. S., Scott I. U., Linder M., Hay D., Feuer W. J., & Chambers K. (2002). Assessment of vision-related function in patients with age-related macular degeneration. Ophthalmology, 109, 720–729.PubMedCrossRefGoogle Scholar
  63. 63.
    Armbrecht A. M., Findlay C., Kaushal S., Aspinall P., Hill A. R., & Dhillon B. (2000). Is cataract surgery justified in patients with age related macular degeneration? A visual function and quality of life assessment. The British Journal of Ophthalmology, 84, 1343–1348.PubMedCrossRefGoogle Scholar
  64. 64.
    Scott I. U., Smiddy W. E., Schiffman J., Feuer W. J., Pappas & C. J. (1999). Quality of life of low-vison patients and the impact of low-vision services. American Journal of Ophthalmology, 128, 54–62.PubMedCrossRefGoogle Scholar
  65. 65.
    Weih L. M., Hassell J. B., & Keeffe J. E. (2002). Assessment of the impact of vision impairment. Investigative Ophthalmology & Visual Science, 43, 927–935.Google Scholar
  66. 66.
    Keeffe J. E., McCarty C. A., Hassell J. B., & Gilbert A. G. (1999). Description and measurement of handicap caused by vision impairment. Australian and New Zealand Journal of Ophthalmology, 27, 184–186.PubMedCrossRefGoogle Scholar
  67. 67.
    Hassell J. B., Lamoureux E. L., & Keeffe J. E. (2006). Impact of age related macular degeneration on quality of life. The British Journal of Ophthalmology, 90, 593–596.PubMedCrossRefGoogle Scholar
  68. 68.
    Lamoureux E. L., Hassell J. B., & Keeffe J. E. (2004). The determinants of participation in activities of daily living in people with impaired vision. American Journal of Ophthalmology, 137, 265–270.PubMedCrossRefGoogle Scholar
  69. 69.
    Stevenson M. R., Hart P. M., Chakravarthy U., Mackenzie G., Bird A. C., Owens S. L., Chisholm I. H., Hall V., Houston R. F., McCulloch D. W., & Plowman N. (2005). Visual functioning and quality of life in the SubFoveal Radiotherapy Study (SFRADS): SFRADS report 2. The British Journal of Ophthalmology, 89, 1045–1051.PubMedCrossRefGoogle Scholar
  70. 70.
    Stevenson M. R., Hart P. M., Montgomery A. M., McCulloch D. W., & Chakravarthy U. (2004). Reduced vision in older adults with age related macular degeneration interferes with ability to care for self and impairs role as carer. The British Journal of Ophthalmology, 88, 1125–1130.PubMedCrossRefGoogle Scholar
  71. 71.
    Mangione C. M., Gutierrez P. R., Lowe G., Orav E. J., & Seddon J. M. (1999). Influence of age-related maculopathy on visual functioning and health-related quality of life. American Journal of Ophthalmology, 128, 45–53.PubMedCrossRefGoogle Scholar
  72. 72.
    Lane S. S., Kuppermann B. D., Fine I. H., Hamill M. B., Gordon J. F., Chuck R. S., Hoffman R. S., Packer M., & Koch D. D. (2004). A prospective multicenter clinical trial to evaluate the safety and effectiveness of the implantable miniature telescope. American Journal of Ophthalmology, 137, 993–1001.PubMedCrossRefGoogle Scholar
  73. 73.
    Hazel C. A., Petre K. L., Armstrong R. A., Benson M. T., & Frost N. A. (2000). Visual function and subjective quality of life compared in subjects with acquired macular disease. Investigative Ophthalmology & Visual Science, 41, 1309–1315.Google Scholar
  74. 74.
    Reeves B. C., Harper R. A., & Russell W. B. (2004). Enhanced low vision rehabilitation for people with age related macular degeneration: A randomised controlled trial. The British Journal of Ophthalmology, 88, 1443–1449.PubMedCrossRefGoogle Scholar
  75. 75.
    Krummenauer F., Braun M., & Dick H. B. (2005). Clinical outcome and subjective quality of life after photodynamic therapy in patients with age-related macular degeneration. European Journal of Ophthalmology, 15, 74–80.PubMedGoogle Scholar
  76. 76.
    Lundstrom M., Brege K. G., Floren I., Lundh B., Stenevi U., & Thorburn W. (2002). Cataract surgery and quality of life in patients with age related macular degeneration. The British Journal of Ophthalmology, 86, 1330–1335.PubMedCrossRefGoogle Scholar
  77. 77.
    Carta A., Braccio L., Belpoliti M., Soliani L., Sartore F., Gandolfi S. A., & Maraini G. (1998). Self-assessment of the quality of vision: Association of questionnaire score with objective clinical tests. Current Eye Research, 17, 506–511.PubMedCrossRefGoogle Scholar
  78. 78.
    Gupta S. K., Viswanath K., Thulasiraj R. D., Murthy G. V., Lamping D. L., Smith S. C., Donoghue M., & Fletcher A. E. (2005). The development of the Indian vision function questionnaire: Field testing and psychometric evaluation. The British Journal of Ophthalmology, 89, 621–627.PubMedCrossRefGoogle Scholar
  79. 79.
    Alonso J., Espallargues M., Andersen T. F., Cassard S. D., Dunn E., Bernth-Petersen P., Norregaard J. C., Black C., Steinberg E. P., & Anderson G. F. (1997). International applicability of the VF-14. An index of visual function in patients with cataracts. Ophthalmology, 104, 799–807.PubMedGoogle Scholar
  80. 80.
    Crabtree H. L., Hildreth A. J., O’Connell J. E., Phelan P. S., Allen D., & Gray C. S. (1999). Measuring visual symptoms in British cataract patients: The cataract symptom scale. The British Journal of Ophthalmology, 83, 519–523.PubMedCrossRefGoogle Scholar
  81. 81.
    Fitzpatrick R., Davey C., Buxton M. J., & Jones D. R. (1998). Evaluating patient-based outcome measures for use in clinical trials. Health Technology Assessment, 2, i, iv–1, 74.Google Scholar
  82. 82.
    Pallant J. F., & Tennant A. (2007). An introduction to the Rasch measurement model: An example using the Hospital Anxiety and Depression Scale (HADS). The British Journal of Clinical Psychology, 46, 1–18.PubMedCrossRefGoogle Scholar
  83. 83.
    Massof R. W., & Fletcher D. C. (2001). Evaluation of the NEI visual functioning questionnaire as an interval measure of visual ability in low vision. Vision Research, 41, 397–413.PubMedCrossRefGoogle Scholar
  84. 84.
    Langelaan M., van Nispen R. M., Knol D. L., Moll A. C., de Boer M. R., Wouters B., & van Rens G. H. (2007). Visual Functioning Questionnaire: Reevaluation of psychometric properties for a group of working-age adults. Optometry and Vision Science 84, 775–784.PubMedCrossRefGoogle Scholar
  85. 85.
    Denny F., Marshall A. H., Stevenson M. R., Hart P. M., & Chakravarthy U. (2007). Rasch analysis of the daily living tasks dependent on vision (DLTV). Investigative Ophthalmology & Visual Science, 48, 1976–1982.CrossRefGoogle Scholar
  86. 86.
    Velozo C. A., Lai J. S., Mallinson T., & Hauselman E. (2000). Maintaining instrument quality while reducing items: Application of Rasch analysis to a self-report of visual function. Journal of Outcome Measurement, 4, 667–680.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media B.V. 2008

Authors and Affiliations

  • Robert P. Finger
    • 1
  • Monika Fleckenstein
    • 1
  • Frank G. Holz
    • 1
  • Hendrik P. N. Scholl
    • 1
  1. 1.Department of OphthalmologyUniversity of BonnBonnGermany

Personalised recommendations